is there much unmet demand for clinical trial populations? could developing countries that get good at organizing clinical trials use this as leverage to build up research capabilities, attract FDI, get lower drug prices, participate in other links in the supply chain?
there is lots of TB in Latin American prisons. should they trial Far UV and ventilation technologies there to combat TB and other respiratory diseases?
if Iran is able to negotiate better access for their gas to markets like Turkey, Pakistan, Bangladesh, East Africa, and India, should we expect faster development and poverty reduction in these countries?
do third world research centers like Embrapa and Fiocruz foster much of a cluster of private sector “spinoffs”?
is the Cuban pharmaceutical sector truly successful and innovative, or is that mostly false propaganda hype? how many developing countries can emulate that without threatening fiscal solvency?